| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |